Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $198 | - | In Stock | |
| 5 mg | $598 | - | In Stock | |
| 10 mg | $960 | - | In Stock | |
| 25 mg | $1,560 | - | In Stock | |
| 50 mg | Preferential | - | In Stock |
| Description | Indatuximab is a chimeric antibody that targets CD13 and is used in the synthesis of the ADC compound indatuximab ravtansine. Indatuximab is being studied for the treatment of multiple myeloma and CD138-positive solid tumors. |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD138 Protein (hFc) at 2 μg/mL can bind Indatuximab. The EC50 is 0.01770 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Syndecan-1/CD138 |
| Molecular Weight | 146.1 kDa |
| Isotype | Human IgG4SP kappa |
| Recommended Isotype Control |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.